Step-up therapy in uncontrolled asthma: Choices and outcomes

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 1, 2009, Pages 122-123

  Sears, Malcolm R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Asthma; inhaled corticosteroids; long acting agonist

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FORMOTEROL; PLACEBO; SALBUTAMOL; SALMETEROL;

ASTHMA; BODY MASS; CIGARETTE SMOKING; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EOSINOPHIL; EXPIRATORY FLOW; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MONOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIOECONOMICS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; REGRESSION ANALYSIS; RISK FACTORS;

EID: 58149117500     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.10.045     Document Type: Editorial

References (15)

1. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
2. Pauwels R.A., Lofdahl C.-G., Postma D.S., Tattersfield A.E., O'Byrne P., Barnes P.J., et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337 (1997) 1405-1411
3. Greening A.P., Ind P.W., Northfield M., Shaw G., and Allen & Hanburys Limited UK Study Group. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344 (1994) 219-224
4. Buhl R., and Vogelmeier C. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Curr Med Res Opin 23 (2007) 1867-1878
5. Beeh K.M., Derom E., Kanniess F., Cameron R., Higgins M., and van As A. Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthma. Eur Respir J 29 (2007) 871-878
6. Thomas M., von Ziegenweidt J., Lee A.J., and Price D. High-dose inhaled corticosteroids versus add-on long acting beta agonists in asthma: an observational study. J Allergy Clin Immunol 123 (2009) 116-121
7. Shepherd G.L., Hetzel M.R., and Clark T.J.H. Regular versus symptomatic aerosol bronchodilator treatment of asthma. Br J Dis Chest 75 (1981) 215-217
8. Castle W., Fuller R., Hall J., and Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 306 (1993) 1034-1037
9. Nelson H.S., Weiss S.T., Bleecker E.R., Yancey S.W., Dorinsky P.M., and SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
10. McIvor R.A., Pizzichini E., Turner M.O., Hussack P., Hargreave F.E., and Sears M.R. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 158 (1998) 924-930
11. 2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 285 (2001) 2583-2593
12. Lemanske R.F., Sorkness C.A., Mauger E.A., Lazarus S.C., Boushey H.A., Fahy J.V., et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 285 (2001) 2594-2603
13. Jayaram L., Pizzichini M.M., Cook R.J., Boulet L.-P., Lemiere C., Pizzichini E., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 (2006) 483-494
14. Sont J.K., Willems L.N.A., Bel E.H., Han J., van Krieken J.M., Vanderbroucke J.P., et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 159 (1999) 1043-1051
15. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173